首页> 外文OA文献 >Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: evidence for a defect in subcutaneous insulin absorption.
【2h】

Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: evidence for a defect in subcutaneous insulin absorption.

机译:通过连续皮下和肌内胰岛素输注治疗严重的脆性糖尿病:皮下胰岛素吸收缺陷的证据。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Severely brittle diabetes is defined as a rare subtype of insulin-dependent diabetes with wide, fast, unpredictable, and inexplicable swings in blood glucose concentration, often culminating in ketoacidosis or hypoglycaemic coma. To assess the role of inappropriate type, amount, or timing of insulin treatment and the route of administration as a cause of severe brittleness six patients with continuous subcutaneous insulin infusion, which provides a high degree of optimisation of dosage with exogenous insulin in stable diabetics. The glycaemic control achieved during continuous subcutaneous insulin infusion was compared with that during continuous intramuscular insulin infusion. Six patients with non-brittle diabetes were also treated by continuous subcutaneous insulin infusion. These patients achieved the expected improvement in glycaemic control (mean +/- SD plasma glucose concentration 5.1 +/- 2.3 mmol/l (92 +/- 41 mg/100 ml)), but not the patients with brittle diabetes remained uncontrolled with continuous subcutaneous infusion (13.6 +/- 5.8 mmol/1 (245 +/- 105 mg/100 ml) compared with 10.3 +/- 4.1 mmol/l (186 +/- 74 mg/100 ml) during treatment with optimised conventional subcutaneous injections). During continuous intramuscular infusion, however, glycaemic control in five of the patients with brittle diabetes was significantly improved (7.7 +/- 2.6 mmol/l (139 +/- 47 mg/100 ml). The remaining patient with brittle diabetes, previously safely controlled only with continuous intravenous insulin, did not respond to continuous intramuscular infusion. It is concluded that in five of the six patients with brittle diabetes studied here impaired or irregular absorption of insulin from the subcutaneous site played a more important part in their hyperlability than inappropriate injection strategies. This absorption defect was presumably bypassed by the intramuscular route.
机译:严重脆性糖尿病定义为胰岛素依赖型糖尿病的罕见亚型,其血糖浓度范围宽,快速,不可预测和无法解释,通常最终导致酮症酸中毒或低血糖昏迷。为了评估胰岛素治疗的不适当类型,数量或时机的作用以及导致严重脆性的给药途径,对六名连续皮下注射胰岛素的患者进行了研究,这为稳定糖尿病患者提供了高度优化的外源性胰岛素剂量。将连续皮下胰岛素输注期间的血糖控制与持续肌肉内胰岛素输注期间的血糖控制进行了比较。还对6例非脆性糖尿病患者进行了连续皮下胰岛素输注治疗。这些患者在血糖控制方面取得了预期的改善(平均+/- SD血浆葡萄糖浓度为5.1 +/- 2.3 mmol / l(92 +/- 41 mg / 100 ml)),但是患有脆性糖尿病的患者并不能保持连续性皮下输注(13.6 +/- 5.8 mmol / 1(245 +/- 105 mg / 100 ml),而优化的常规皮下注射治疗期间为10.3 +/- 4.1 mmol / l(186 +/- 74 mg / 100 ml) )。然而,在连续肌注过程中,五名脆性糖尿病患者的血糖控制得到了显着改善(7.7 +/- 2.6 mmol / l(139 +/- 47 mg / 100 ml)。结论:在本研究中,六名患有脆性糖尿病的患者中有五名从皮下部位吸收或不规律地吸收胰岛素,对他们的高脂血症起着比不适当的更重要的作用。注射策略:这种吸收缺陷可能被肌肉内途径绕开了。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号